Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Moderna Sliding Lower as EU Postpones Additional COVID Booster Deliveries, Pfizer and Novavax on Watch

Published 06/02/2022, 02:57 AM
Updated 06/02/2022, 06:58 AM
© Reuters Moderna (MRNA) Sliding Lower as EU Postpones Additional COVID Booster Deliveries, Pfizer (PFE) and Novavax (NVAX) on Watch

© Reuters Moderna (MRNA) Sliding Lower as EU Postpones Additional COVID Booster Deliveries, Pfizer (PFE) and Novavax (NVAX) on Watch

By Vlad Schepkov

Shares of Moderna (NASDAQ:MRNA) are trading 2% lower Thursday morning as the company announced it had agreed to amend the delivery schedule of additional COVID-19 vaccine booster shots to the European Union.

The agreement, the first public announcement of its kind, is allowing participating EU Member States to postpone deliveries of Moderna's vaccine booster doses currently scheduled for later in 2022 or even early 2023.

It's too early to tell whether other countries will follow suit, and what effect such postponements may have on Moderna's bottom line, although negative financial implications can’t be ruled out. The company, on its end, continues "to expect advanced purchase agreements of approximately $21 billion for 2022 and continues to believe that COVID market dynamics will result in sales slightly higher in the second half of 2022 than in the first half."

The news comes as global COVID-19 case counts continue to decline - on June 1st there were "only" 655K new cases reported globally. This compares to ~1.1M daily cases reported 2 months prior, and nearly 3.7M daily cases at the height of the January 2022 COVID surge.

So far there's no noticeable chain reaction in other COVID-19 vaccine-dependent stocks - both Novavax (NASDAQ:NVAX) and Pfizer (NYSE:PFE) remain relatively quiet pre-market.

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.